SACKLER Act

Hozzl · 2024-03-13T17:20:45Z

Explore the details of Senate Bill 2831 SACKLER Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Finance and Financial Sector. Stay informed on legislative developments.

3/13/2024, 5:20 PM

Summary of Bill S 2831

The SACKLER Act, also known as Bill 118 s 2831, is a piece of legislation introduced in the US Congress. The purpose of this bill is to hold pharmaceutical companies accountable for their role in the opioid crisis. The bill specifically targets the Sackler family, who are the owners of Purdue Pharma, the company responsible for manufacturing OxyContin.

The SACKLER Act aims to impose a tax on the profits made by pharmaceutical companies from the sale of opioids. This tax would be used to fund programs and initiatives aimed at addressing the opioid crisis, such as addiction treatment and prevention programs.

Additionally, the bill seeks to prevent the Sackler family from profiting off of the sale of opioids by requiring them to pay back any profits made from the sale of OxyContin. This would help ensure that those responsible for fueling the opioid crisis are held accountable for their actions. Overall, the SACKLER Act is a bipartisan effort to address the devastating impact of the opioid crisis and hold pharmaceutical companies accountable for their role in perpetuating it.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 2831

Bill S 2831 is currently in the status of Bill Introduced since September 18, 2023. Bill S 2831 was introduced during Congress 118 and was introduced to the Senate on September 18, 2023. Bill S 2831's most recent activity was Read twice and referred to the Committee on the Judiciary. as of September 18, 2023

Bipartisan Support of Bill S 2831

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 2831

Primary Policy Focus

Finance and Financial Sector

Alternate Title(s) of Bill S 2831

SACKLER Act

Stop shielding Assets from Corporate Known Liability by Eliminating non-debtor Releases Act

A bill to prohibit the non-consensual release of claims by States, municipalities, federally recognized Tribes, or the United States against non-debtors, and for other purposes.